Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

HGS initiates phase I trial of Albuferon as treatment for HCV

April 2, 2001

FDA grants priority review status for Entocort modified-release capsules

April 2, 2001

PEG-Intron/Rebetol combination for hepatitis C treatment approved in E.U.

March 30, 2001

Mechanism of gastroprokinetic effects of Z-338 discussed at recent scientific meeting

March 29, 2001

Intravenous formulation of Protonix approved by FDA for GERD

March 29, 2001

TAK-637 effective against the diarrhea and pain characteristic of IBS

March 27, 2001

Schering-Plough receives notification of priority review status for PEG-Intron/Rebetol sBLA

March 27, 2001

AstraZeneca's Nexium for erosive esophagitis launched in U.S.

March 23, 2001

Adolor's opioid gastrointestinal drug enters late-stage clinical development

March 22, 2001

Isis and Merck & Co. extend HCV collaboration

March 21, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...